Department of Obstetrics & Gynecology, Tel Aviv Sourasky Medical Center, Lis Hospital for Women, Tel Aviv University, Tel Aviv, Israel.
The Hebrew University Hadassah Medical School, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Acta Obstet Gynecol Scand. 2021 Sep;100(9):1620-1626. doi: 10.1111/aogs.14198. Epub 2021 Jun 19.
The association between the degree of isolated gestational proteinuria and preeclampsia with severe features and other placental-mediated complications is controversial. The aim of this study was to evaluate whether a higher isolated proteinuria level is associated with an increased frequency of preeclampsia with severe features.
This retrospective cohort study included pregnant women who were past 24 weeks of gestation and were diagnosed as having new-onset proteinuria ≥300 mg in a 24-h urine collection. Exclusion criteria included diagnosis of preeclampsia within 72 h from admission, chronic renal disease or chronic hypertension. The study population was divided into tertiles by proteinuria level and the association with preeclampsia with severe features was assessed in both bivariable and multivariable analysis. The main outcome measures was the development of preeclampsia with severe features.
Overall, 165 women were diagnosed with isolated gestational proteinuria, and 38 (23.0%) of them developed preeclampsia with severe features. Women in the increasing proteinuria tertile were more likely to develop preeclampsia with severe features (5.5%, 21.8%, 41.8%, respectively; p = 0.004). A multivariable logistic regression model controlling for background characteristics as well as gestational age at diagnosis, blood pressure, and kidney and liver function tests showed an increased risk of 14% to develop preeclampsia with severe features for every 500-mg rise in proteinuria level (adjusted odds ratio = 1.14, 95% confidence interval 1.03-1.27).
A higher isolated gestational proteinuria level was associated with an increased risk to develop preeclampsia with severe features among pregnant women past 24 weeks of gestation.
孤立性妊娠期蛋白尿的程度与子痫前期严重表现和其他胎盘介导的并发症之间的关联存在争议。本研究旨在评估较高的孤立性蛋白尿水平是否与子痫前期严重表现的发生频率增加有关。
这项回顾性队列研究纳入了孕周超过 24 周且在 24 小时尿液收集时诊断为新出现的蛋白尿≥300mg 的孕妇。排除标准包括入院后 72 小时内诊断为子痫前期、慢性肾脏疾病或慢性高血压。根据蛋白尿水平将研究人群分为三分位组,并在单变量和多变量分析中评估其与子痫前期严重表现的关联。主要结局指标为子痫前期严重表现的发生。
总体而言,165 名孕妇被诊断为孤立性妊娠期蛋白尿,其中 38 名(23.0%)发生子痫前期严重表现。蛋白尿水平递增组发生子痫前期严重表现的可能性更高(分别为 5.5%、21.8%、41.8%;p=0.004)。多变量逻辑回归模型控制了背景特征以及诊断时的孕周、血压以及肾脏和肝功能检查,结果显示,蛋白尿水平每增加 500mg,发生子痫前期严重表现的风险增加 14%(调整后的优势比=1.14,95%置信区间 1.03-1.27)。
在孕周超过 24 周的孕妇中,较高的孤立性妊娠期蛋白尿水平与发生子痫前期严重表现的风险增加相关。